Increasing Adoption Of Risk Of Chronic Pain Patients Drives Growth In The Chronic Pain Market Is Influencing The Chronic Pain Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Increase In Market Value Is Predicted For The Chronic Pain Market During The 2026–2030 Period?

The chronic pain market has experienced robust expansion in recent years. It is anticipated to increase from $84.66 billion in 2025 to $91.67 billion in 2026, at a compound annual growth rate (CAGR) of 8.3%. The historical period’s growth can be attributed to the rising prevalence of chronic diseases, an increase in neuropathic and musculoskeletal pain cases, the broader availability of pain medications, enhanced clinical recognition of chronic pain, and the proliferation of pain clinics.

The chronic pain market is projected to experience substantial growth in the coming years, with its size anticipated to reach $127.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This expansion during the forecast period is driven by factors such as a heightened demand for personalized pain therapies, the increasing implementation of bioelectronic devices, the wider availability of telehealth-based pain care, a greater emphasis on opioid alternatives, and boosted investment in pain research. Key developments anticipated in this period include the wider acceptance of multidisciplinary pain care models, an uptick in the utilization of neuromodulation devices, a growing preference for non-opioid drug therapies, the proliferation of home-based pain management solutions, and improved incorporation of digital health platforms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp

What Primary Factors Are Fueling The Expansion Of The Chronic Pain Market?

The increasing number of chronic pain patients is anticipated to drive the expansion of the chronic pain market. Chronic pain patients are defined as individuals experiencing persistent or long-lasting pain that extends beyond the typical healing period or continues for an extended duration, usually exceeding three months. This significant prevalence among chronic pain patients stimulates the growth of the chronic pain market, as the rising need for effective pain management solutions, including both pharmaceuticals and medical devices, fosters opportunities for innovation and development within the industry. For instance, in June 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that an estimated 4.0 million Australians (16% of the population) were living with back problems in 2022. By 2023, back problems had become the third leading cause of disease burden, contributing to 4.3% of the country’s total disease burden. Additionally, in February 2024, a report from the Institute for Health Metrics and Evaluation, a US-based national and international public health agency and research institute, projected that global cases of neck pain are expected to reach 269 million by 2050 (ranging from 219 to 322 million). Thus, the widespread occurrence of chronic pain patients is a key driver for the growth of the chronic pain market.

How Is The Chronic Pain Market Distributed Across Key Segments?

The chronic pain market covered in this report is segmented –

1) By Product: Drug, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By End User: Hospitals, Clinics, Research Organization

Subsegments:

1) By Drug: Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, Corticosteroids

2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat And Cold Therapy Devices, Bioelectronic Devices

What Trends Are Shaping The Chronic Pain Market Structure?

Major companies operating within the chronic pain market are adopting a strategic partnership approach to launch a shared savings program for the management of chronic pain. Strategic partnerships describe a process where companies leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in August 2023, MOBE, a US-based digital health innovator company, partnered with Override Health, a US-based healthcare company. With this collaboration, they aim to address the management of chronic pain through a shared savings program that integrates their respective expertise. MOBE, as a health outcomes company, utilizes healthcare data analytics to inform its high-touch, one-to-one health coaching and medication management model. On the other hand, Override delivers an integrated program of virtual interdisciplinary care, neuroplasticity-centered coaching, and peer support to help individuals with chronic pain navigate the complexity of disconnected care.

Who Are The Leading Firms Participating In The Chronic Pain Market?

Major companies operating in the chronic pain market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

Access The Complete Chronic Pain Market Report:

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Which Region Commands The Largest Share Of The Chronic Pain Market?

North America was the largest region in the chronic pain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Chronic Pain Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=11970&type=smp

Browse Through More Reports Similar to the Global Chronic Pain Market 2026, By The Business Research Company

Virtual Reality Vr In Medical Simulation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-reality-vr-in-medical-simulation-global-market-report

Virtual Reality Software Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-reality-software-global-market-report

Virtual Reality Vr Fitness Game Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-reality-vr-fitness-game-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795